Evidence map›Paper›PMID 15123833›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2004

Genome-wide somatic hypermutation.

Clifford L Wang, Ryan A Harper, Matthias Wabl

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Probing pathways of adaptation with continuous evolution.Current opinion in systems biology · 2019
    Article
  7. An Adaptable Platform for Directed Evolution in Human Cells.Journal of the American Chemical Society · 2018
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Tuning gene expression with synthetic upstream open reading frames.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Clifford L WangDepartment of Microbiology and Immunology, University of California-San Francisco, San Francisco, CA 94143, USA. cliffw@itsa.ucsf.edu
Ryan A Harper
Matthias Wabl

Funding

MOLECULAR AND CELLULAR IMMUNOLOGYT32AI007334 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CYSTER, JASON G · 1988 to 2023
$11.0M
Genetic Variation in B-Lymphocyte OntogenyR01AG020684 · NIA · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI WABL, MATTHIAS R · 2001 to 2005
$1.7M
NIAID NIH HHS T32 AI007334NIAID NIH HHS T32 AI 07334NIA NIH HHS AG 20684NIA NIH HHS R01 AG020684
6 · The paper itself

Abstract

DNA mutagenesis is generally considered harmful. Yet activated B cells normally mutate the Ig loci. Because this somatic hypermutation is potentially dangerous, it has been hypothesized that mutations do not occur throughout the genome but instead are actively targeted to the Ig loci. Here we challenge this longstanding and widely accepted hypothesis. We demonstrate that hypermutation requires no Ig gene sequences. Instead, activation-induced cytidine deaminase and other trans-acting hypermutation factors may function as general mutators.

Indexed as

GenomeMutationCell LineGenes, Reporter

Identifiers

PMID15123833
PMCPMC409922

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.